Cargando…
Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
Reactivation of human cytomegalovirus (HCMV) in transplant recipients can cause life-threatening disease. Consequently, for transplant recipients, killing latently infected cells could have far-reaching clinical benefits. In vivo, myeloid cells and their progenitors are an important site of HCMV lat...
Autores principales: | Krishna, B. A., Spiess, K., Poole, E. L., Lau, B., Voigt, S., Kledal, T. N., Rosenkilde, M. M., Sinclair, J. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296658/ https://www.ncbi.nlm.nih.gov/pubmed/28148951 http://dx.doi.org/10.1038/ncomms14321 |
Ejemplares similares
-
Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells
por: Spiess, Katja, et al.
Publicado: (2017) -
HCMV Antivirals and Strategies to Target the Latent Reservoir
por: Perera, Marianne R., et al.
Publicado: (2021) -
Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies
por: De Groof, Timo W. M., et al.
Publicado: (2021) -
Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells
por: Krishna, B. A., et al.
Publicado: (2016) -
Cytomegalovirus establishes a latent reservoir and triggers long-lasting inflammation in the eye
por: Voigt, Valentina, et al.
Publicado: (2018)